Sophia Genetics SA
SOPH3.300USD
+0.140+4.43%
收盘 08/04, 16:00（美东）报价延迟15分钟
220.51M总市值
亏损市盈率 TTM
关于 Sophia Genetics SA 公司
Sophia Genetics SA 是一家总部位于瑞士的公司，从事软件出版行业。该公司提供基于云的软件即服务平台 - SOPHiA DDM，这是一个数据驱动的医疗平台，可以从不同的复杂数据集中获取见解，以改善诊断、治疗和药物开发。该公司在瑞士、法国和英国设有办事处，业务遍布全球。
公司简介
公司代码SOPH
公司名称Sophia Genetics SA
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
员工数量423
证券类型Ordinary Share
年结日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ Global Select Consolidated
国家Switzerland
邮编1180
电话41216941060
网址https://www.sophiagenetics.com/
公司代码SOPH
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
60.38K
+51.32%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.60K
-5.14%
Mr. Milton G. Silva-Craig, J.D.
Mr. Milton G. Silva-Craig, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
Rest of EMEA
5.51M
31.00%
France
2.61M
14.70%
Italy
2.53M
14.23%
United States
2.48M
13.95%
Spain
1.42M
7.97%
Other
3.23M
18.15%
业务
地区
暂无数据
股东统计
更新时间: 7月23日 周三
更新时间: 7月23日 周三
持股股东
股东类型
持股股东
持股股东
占比
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
持股股东
持股股东
占比
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
股东类型
持股股东
占比
Investment Advisor
17.54%
Investment Advisor/Hedge Fund
16.07%
Venture Capital
13.28%
Family Office
10.52%
Individual Investor
6.53%
Hedge Fund
0.91%
Bank and Trust
0.46%
Pension Fund
0.14%
Other
34.55%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
89
36.68M
54.88%
-257.44K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
2023Q2
90
31.34M
48.19%
-3.70M
2023Q1
86
30.07M
46.79%
+1.58M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Alychlo NV
6.99M
10.46%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.16%
--
--
Mar 31, 2025
aMoon Fund
5.51M
8.25%
+577.36K
+11.70%
Feb 15, 2025
UBS Asset Management (Switzerland)
4.54M
6.79%
+2.34M
+106.14%
Mar 31, 2025
Akre Capital Management, LLC
3.72M
5.57%
+1.48M
+66.22%
Jun 20, 2025
Balderton Capital (UK) LLP
3.36M
5.03%
--
--
Feb 15, 2025
UBS Asset Management (Americas) LLC
3.10M
4.64%
+3.10M
--
Mar 31, 2025
Camblong (Jurgi)
2.65M
3.97%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.31%
-32.20K
-1.44%
Mar 31, 2025
Principal Global Investors (Equity)
1.39M
2.07%
-43.33K
-3.03%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
占比0%
Fidelity Nasdaq Composite Index ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
